Cordis
This article was originally published in The Gray Sheet
Executive Summary
Plans to file premarket approval application for its electrophysiology catheter for radiofrequency ablation "within the next month," according to a spokesperson for the firm. Cordis joins Medtronic, with a PMA for an RF ablation catheter on file at FDA, and EP Technologies, whose RF ablation catheter won a recommendation for approval from FDA's Circulatory System Devices Panel in May ("The Gray Sheet" May 9, p. 2)